Reuters reports:
The U.S. Supreme Court on Monday is set to hear a challenge by President Joe Biden’s administration to the legality of OxyContin maker Purdue Pharma’s bankruptcy settlement, a deal that if approved would shield its wealthy Sackler family owners from lawsuits over their role in the country’s opioid epidemic.
Purdue’s owners under the settlement would receive immunity in exchange for paying up to $6 billion to settle thousands of lawsuits filed by states, hospitals, people who had become addicted and others who have sued the Stamford, Connecticut-based company over its misleading marketing of the powerful pain medication OxyContin.
Read the full article.
US Supreme Court set to review Purdue Pharma bankruptcy settlement https://t.co/aj9v8fsPEV https://t.co/aj9v8fsPEV
— Reuters Health (@Reuters_Health) December 4, 2023